Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ